Experience
AbbVie Inc.
Amgen Inc.
Represented AbbVie in Biologics Price Competition and Innovation (BPCIA) litigation related to Humira®.
AbbVie Inc. v. Amgen Inc., 1:16-cv-00666, D. Del., Judges Fallon, Goldberg, Robinson
Zimmer Surgical, Inc. et al. v. Stryker Corporation et al.
Zimmer Surgical, Inc.
Aerin Medical Inc. et al. v. Neurent Medical Inc. et al.
Aerin Medical Inc. et al.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
AgroFresh Inc. v. Decco U.S. Post-Harvest, Inc. et al.
Decco US Post-Harvest, Inc.
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al.
BioDelivery Sciences International, Inc. et al.
AbbVie Inc. et al v. Alvotech hf.
AbbVie Inc. et al
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
Novartis Gene Therapies, Inc. et al.
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.
BioDelivery Sciences International, Inc. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.